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Carrier status for autosomal-recessive disorders is gener-
ally considered clinically irrelevant until it comes time
to estimate reproductive risks. For sickle cell disease,
this isn’t completely true; the red blood cells of carriers
of the sickle cell mutation can change morphology
under extreme conditions, such as when the individual
is dehydrated or at high altitude. Using combined data
of nearly 16,000 individuals from five prospective
studies, Naik et al. recently found evidence that more
general health risks are associated with sickle cell carrier
status. They document an increased risk of chronic kid-
ney disease and albuminuria in African American car-
riers of sickle cell mutations, as well as a larger decline
in glomerular filtration rate in these carriers than in
non-carriers. It follows that population differences in
the sickle cell mutation frequency might contribute to
the well-documented differences in incidence of kidney
disease between different racial groups in the United
States.
Naik et al. (2014). JAMA 312, 2115–2125.
Give Me Some Skin
Epidermolysis bullosa is a severe skin disorder in which
even the slightest friction can lead to skin blistering. Other
than avoiding skin damage, treatment is supportive and
the condition debilitating. Three recent papers explore
the use of patient-derived induced pluripotent stem cells
(iPSCs) to create skin grafts. In culture, Sebastiano et al.
used adenovirus-associated viral genome editing to correct
the COL7A1 mutation in patient-derived iPSCs that were
then differentiated into keratinocytes. Umegaki-Akao
et al. had the same basic idea, but rather than correcting
the causative mutation themselves, they generated iPSCs
starting with patient cells in which themutation had spon-
taneously reverted. In a preclinical trial of this therapeutic
approach, Wenzel et al. corrected the relevant Col7a1
mutation in iPSCs derived from a mouse model of epider-
molysis bullosa. Differentiated fibroblasts were injected
into affected mice, and this cellular therapy improved
skin integrity and led to type VII collagen deposition,
opening the door for further exploration of this approach
for use in people.
Sebastiano et al. (2014). Sci. Transl. Med. 6, 264ra163.
Umegaki-Arao et al. (2014). Sci. Transl. Med. 6, 264ra164.
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ThLong-Term Follow-up of Children at Risk of Brugada
Syndrome
Brugada syndrome is a cardiac arrhythmia that puts
affected individuals at risk of sudden death. Because it is
autosomal dominant, identification of one affected indi-
vidual generally leads to screening of multiple family
members. Often, this screening is performed through
electrocardiogram (ECG) rather than genetic testing, and
a characteristic wave pattern in conjunction with symp-
toms or a family history of sudden cardiac death is consid-
ered diagnostic. This ECG finding occurs spontaneously
in some individuals but can be unmasked in others via
sodium channel blockers, such as ajmaline. The timing
of this screening has been controversial. Although chil-
dren are at risk of sudden death, the risk is lower than it
is in adulthood, but a clean ECG could mean that they
are in the clear—or does it? Conte et al. report the results
of repeat post-pubertal ajmaline testing following an initial
negative test in childhood. Close to one-quarter of the 53
individuals who initially tested negative had a positive
repeat test, and four of them developed clinical symptoms.
This suggests that negative screening for Brugada syn-
drome in childhood—even when done in conjunction
with drug provocation—does not rule out disease, a result
that should help with the further development of
screening strategies for at-risk individuals.
Conte et al. (2014). JAMA 312, 2039–2041.
Better by Half
Although declared finished, the human genome reference
sequence contains gaps that have been refractory to assem-
bly. Whether it is because the sequences in these gaps are
toxic to the bacteria in which they were cloned as the
genome was assembled or because they don’t map
uniquely to one location, it has been difficult to close these
gaps despite the years that have elapsed since the genome
was ‘‘finished.’’ To overcome the challenges in completing
the sequence in these regions, Chaisson et al. used two
innovations that ultimately enabled them to close about
50% of these gaps in the human genome. First, they started
with a cell line derived from a complete hydatidiform
mole. These cells derive from a monospermic fertilization
event followed by a complete genome duplication, and
in essence, they only have one copy of the genome. This
makes sequence assembly easier, and it also means that
there is increased effective sequence coverage. Second,ta, GA 30322, USA
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the authors used single-molecule real-time sequencing in
which the DNA was sequenced in reads over 5 kb without
the need for cloning and/or amplification. Through this
approach, the groupmade it through half of the remaining
interstitial genomic gaps, many of which contained long
runs of short tandem repeats.
Chaisson et al. (2014). Nature. Published online November
10, 2014. http://dx.doi.org/10.1038/nature13907.
Initiating Change
Recombination is a crucial process that increases genetic
diversity and also ensures proper chromosome segrega-
tion during meiosis. It is initiated by double-strand
breaks, but we have an incomplete understanding of
the early steps of this process, partly because we have
only been able to assess recombination when a genetic
crossover happens, and this is only a subtype of homolo-
gous recombination events. Pratto et al. used chromatin
immunoprecipitation followed by single-stranded DNA4 The American Journal of Human Genetics 96, 3–4, January 8, 2015sequencing in order to understand recombination initia-
tion on a more individual level. They sought DNA
fragments associated with DMC1, a specific marker of
double-strand breaks. Recombination maps were gener-
ated for individual men and compared according to their
genotype at PRDM9, which encodes a protein that defines
hotspots of recombination. Extending what had been
documented at specific genomic locations, they found
that the PRDM9 genotype influences hotspot distribution
across the genome. Combined across PRDM9 genotypes,
the recombination hotspots correlate with many of those
identified in population averaged linkage-disequilibrium
maps. The hotspots defined by the most common
PRDM9 allele were also found to coincide with chromo-
some breakpoints for disease-associated recurrent copy-
number variants, suggesting that the PRDM9 genotype
might influence propensity toward the occurrence of
these genomic disorders.
Pratto et al. (2014). Science 346, 1256442.This Month in Our Sister JournalsSimultaneous Testing of Multiple Markers in
Genome-wide Association Studies
Although the concept of complex traits encompasses
phenotypes that are governed by variation at multiple
positions in the genome, this is not how these traits are
treated when they are dissected. Instead, polymorphisms
are assessed one at a time for determining their influence
on a trait. Even with genome-wide association studies,
single SNPs are assessed individually for their contribution
to the trait of interest. To better model the likely biologicalreality of complex traits, Yi et al. explored the use of penal-
ized regression approaches for genetic association studies.
In this method, genotyped markers can be subsetted or
analyzed as a whole for association with a quantitative
trait. The authors compared their approach to marker-by-
marker approaches on simulated and real data and found
that the penalized regression method has more power
while still controlling the false-discovery rate.
Yi et al. (2014). Genetics. Published online October 28,
2014. http://dx.doi.org/10.1534/genetics.114.167817.
